
When 'catastrophic' is applied as an adjective to the antiphospholipid syndrome, it implies a characteristic presentation due to predominantly small blood vessel thrombosis leading to rapidly progressive failure of multiple organs and a frequently fatal outcome. We present the case of a 48-year-old woman who presented with the 'catastrophic' antiphospholipid syndrome without previous history of coagulation disorder or connective tissue disease that illustrates the difficulties in diagnosing and managing this disorder. We also review the factors that have been reported to have a role in the development of this condition and show how this case throws light on its pathogenesis.
Respiratory Distress Syndrome, Critical Illness, Prednisolone, Anti-Inflammatory Agents, Anticoagulants, Middle Aged, Antiphospholipid Syndrome, Methylprednisolone, White People, Treatment Outcome, Antirheumatic Agents, Humans, Female, Warfarin, Hydroxychloroquine
Respiratory Distress Syndrome, Critical Illness, Prednisolone, Anti-Inflammatory Agents, Anticoagulants, Middle Aged, Antiphospholipid Syndrome, Methylprednisolone, White People, Treatment Outcome, Antirheumatic Agents, Humans, Female, Warfarin, Hydroxychloroquine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 11 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
